✦ LIBER ✦

Role of anti-interferon antibodies in breakthrough occurrence during alpha 2a and 2b therapy in patients with chronic hepatitis C

✍ Scribed by Vincent Leroy; Marilyne Baud; Caroline de Traversay; Marianne Maynard-Muet; Pierre Lebon; Jean-Pierre Zarski

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with interferon alph

✍ J. Juszczyk; B. Bolewska; J. Cianciara; J. Jablonska; P. Zaborowski; D. Niedzial 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

One-year interferon-alpha2a therapy in h

✍ Lavaud, S; Hanrotel, C; Brodard, V; Toupance, O; Diébold, MD; Ingrand, D; Thiéfi 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 166 KB

The Changes in Quantitative HCV RNA Tite

✍ Myron J. Tong Ph.D.; M.D.; Lawrence M. Blatt Dr. P.H.; M.B.A.; Andrew Conrad Ph. 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 46 KB

Prevalence of breakthrough in chronic he

✍ Giorgio Bellati; Guido Colloredo; Luigi Roffi; Maurizio D'Aquino; Ferruccio Boni 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 254 KB

A case of polymyositis in a chronic hepa

✍ Yusuke Okuma; Kiminori Kimura; Shunichi Saeki; Tsunekazu Hishima; Seishu Hayashi 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 244 KB

PP-131 Biochemical Response with interfe

✍ Adnan Raja; Muhammad Umar; Hammamatul Bushra 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB